Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial

Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a potential update or modification in the context of a clinical study related to the effectiveness and safety of GLPG1690 for participants with Idiopathic Pulmonary Fibrosis (IPF) when used alongside standard care.
    Difference
    0.1%
    Check dated 2024-06-06T14:17:13.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    19 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation. The value has been updated to provide detailed eligibility criteria for researchers looking for participants with Idiopathic Pulmonary Fibrosis (IPF) in clinical research studies.
    Difference
    30%
    Check dated 2024-05-21T19:21:27.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:39:45.000Z thumbnail image

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.